There were 2,498 press releases posted in the last 24 hours and 438,060 in the last 365 days.

Generex Product Available Throughout New York City

December 3, 2009 (FinancialWire) — Generex Biotechnology Corp. (NASDAQ: GNBT) (www.generex.com), a leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced that the company’s proprietary Crave-NX 7-Day Diet Aid Spray will soon be available in Duane Reade’s 256 drugstores throughout New York City.

Crave-NX 7-Day Diet Aid Spray is a great tasting orange-flavored formulation, sprayed and administered into the mouth, scientifically formulated to quickly curb cravings throughout the day, saving valuable calories. The product has been clinically-tested, has 20 servings per bottle, with only two calories per serving and zero fat. Crave-NX is a brand new diet aid that can help “Spray the Crave Away” while saving calories by controlling the user’s sweet tooth and junk food cravings throughout the day, which can save up to 1,000 calories per day.

Over a one-year period, saving just 250 calories per day adds up to over 90,000 calories — or 26 pounds. Crave-NX is a product that is positioned to complement other diet products and/or programs, which provide incremental sales for retailers and a new diet add-on solution for the consumer.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports, filings and conference call webcasts for companies mentioned in the news are available via Investrend Syndications (http://investrend.ar.wilink.com/?level=279). The most recently issued reports and/or recorded webcasts include Cascade Corp. (NYSE: CASC), Anadarko Petroleum Corp. (NYSE: APC), Baytex Energy Trust (NYSE: BTE) (TSX: BTE), H & Q Healthcare Investors (NYSE: HQH), H & Q Life Science Investors (NYSE: HQL), PIMCO (NYSE: PYN) (NYSE: PMX) (NYSE: PZC), PIMCO Global StocksPLUS & Income Fund (NYSE: PGP), Taiwan Greater China Fund (NYSE: TFC) and Wolseley PLC (OTC: WOSCF) (London Stock Exchange: WOS).

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.